Allied World Assurance Company Holdings (AWH) - FREE Research Report

Knight W. Gordon who is President, AWACUS & AWNAC at Allied World Assurance Company Holdings sold 750 shares at $99.21 on Oct. 2, 2013. Following this transaction, the President, AWACUS & AWNAC owned 21,683 shares meaning that the stake was reduced by 3.34% with the 750 share transaction.

The shares most recently traded at $101.72, up $2.51, or 2.47% since the insider transaction. Historical insider transactions for Allied World Assurance Company Holdings go as follows:

  • 4-Week # shares sold: 750
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 1,500
  • 24-Week # shares sold: 8,750

The average volume for Allied World Assurance Company Holdings has been 159,600 shares per day over the past 30 days. Allied World Assurance Company Holdings has a market cap of $3.3 billion and is part of the financial sector and insurance industry. Shares are up 24.07% year to date as of the close of trading on Wednesday.

Allied World Assurance Company Holdings, AG, through its subsidiaries, provides property and casualty insurance and reinsurance solutions in Bermuda, the United States, Europe, Hong Kong, Labuan, and Singapore. The company operates through three segments: U.S. The stock currently has a dividend yield of 2.05%. The company has a P/E ratio of 10.5. Currently there are 2 analysts that rate Allied World Assurance Company Holdings a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AWH - FREE

TheStreet Quant Ratings rates Allied World Assurance Company Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Allied World Assurance Company Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

European Pharma Companies Slip on MS Pricing Probe

Biogen Stock Climbs After Goldman Adds to its 'Conviction Buy' List

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire